Alpha Cure Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Alpha Cure Therapeutics General Information

Description

Developer of precision radioligand therapy designed to treat genetically targeted cancers with minimal toxicity. The company specializes in dual-action small molecule delivery, neutron-triggered alpha particle release, and mutation-specific targeting, enabling oncology patients to receive individualized treatment with reduced damage to healthy tissue.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Lynnfield, MA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Lynnfield, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alpha Cure Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 30-Oct-2025 Completed Startup
To view Alpha Cure Therapeutics’s complete valuation and funding history, request access »

Alpha Cure Therapeutics Patents

Alpha Cure Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260315599-A1 Small molecule modified boron containing compounds and methods of use thereof Pending 25-Mar-2024

Alpha Cure Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alpha Cure Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bioincubator Accelerator/Incubator
To view Alpha Cure Therapeutics’s complete investors history, request access »

Alpha Cure Therapeutics FAQs

  • When was Alpha Cure Therapeutics founded?

    Alpha Cure Therapeutics was founded in 2024.

  • Where is Alpha Cure Therapeutics headquartered?

    Alpha Cure Therapeutics is headquartered in Lynnfield, MA.

  • What is the size of Alpha Cure Therapeutics?

    Alpha Cure Therapeutics has 2 total employees.

  • What industry is Alpha Cure Therapeutics in?

    Alpha Cure Therapeutics’s primary industry is Drug Discovery.

  • Is Alpha Cure Therapeutics a private or public company?

    Alpha Cure Therapeutics is a Private company.

  • What is Alpha Cure Therapeutics’s current revenue?

    The current revenue for Alpha Cure Therapeutics is .

  • Who are Alpha Cure Therapeutics’s investors?

    Bioincubator has invested in Alpha Cure Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process